845-025-7090 Cannabinoid Edible Labeling Requirements Prior to a cannabinoid edible being sold or transferred to a consumer, patient or designated primary caregiver the container holding the edible must have a label that has the following information: (1) Processor’s business or trade name, place of address, and license number; (2) Business or trade name and place of address of licensee that packaged the product, if different from the processor; (3) Product identity; (4) UID number; (5) Date the edible was made; (6) Net weight or volume in U.S. customary and metric units; (7) Serving size and number of servings per container; (8) Amount, in milligrams, of THC and CBD in each serving and in the container; (9) List of all ingredients in descending order of predominance by weight or volume used to process the cannabinoid edible; (10) List of potential major food allergens: (a) Using a “contains” statement list the name of the food source of any major food allergen at the end of or immediately adjacent to the ingredient list; or (b) Placing the term for the appropriate major food allergen in parenthesis within the ingredient list after the common or usual name of the ingredient derived from that major food allergen; (11) The amount of calories, sodium, protein, added sugars, cholesterol, total carbohydrates, and total fat per serving, in grams or milligrams as appropriate. On and after January 1, 2026, the required nutrient, vitamin, and mineral information in 21 CFR 101.9(c) for nutrition labeling of food. Optional nutrient, vitamin, and mineral information as allowed in 21 CFR 101.9(c) may be listed. Nothing in this rule precludes the use of the required or optional nutrient, vitamin, or mineral information before January 1, 2026. (12) If the edible is perishable, a statement that the edible must be refrigerated or kept frozen; (13) Name of the lab that performed any test and any test analysis date; (14) Activation time, expressed in words or through a pictogram; (15) Universal symbol; (16) A statement that reads: “This product is not approved by the FDA to treat, cure, or prevent any disease”; (17) For cannabinoid edibles for sale to a consumer, warnings that state: (a) “For use only by adults 21 and older. Keep out of reach of children.” (b) “Do not drive a motor vehicle while under the influence of marijuana.” (c) “BE CAUTIOUS” in bold, capital letters, followed by “Cannabinoid edibles can take up to 2 hours or more to take effect.” (18) For medical grade cannabinoid edibles for use by a patient, the medical grade symbol and medical warnings that state: (a) “For use by OMMP patients only. Keep out of reach of children.” (b) “Do not drive a motor vehicle while under the influence of marijuana.” (c) “BE CAUTIOUS” in bold, capital letters, followed by “Cannabinoid edibles can take up to 2 hours or more to take effect.” (19) For all beverage containers that require a refund value under ORS 459A.702, the label must contain “OR 10¢.” Statutory/Other Authority: ORS 475C.604 Statutes/Other Implemented: ORS 475C.604 History: OLCC 12-2024, amend filed 12/20/2024, effective 01/01/2025 OLCC 151-2022, minor correction filed 03/25/2022, effective 03/25/2022 OLCC 6-2018, adopt filed 05/23/2018, effective 06/01/2018